Zentiva Snaps Up Alvogen’s CEE Operations

Alvogen To Focus On Asia And Alvotech’s Biosimilars

Acquiring Alvogen’s operations in central and eastern Europe will strengthen private equity-backed Zentiva’s presence in both the generics and OTC markets.  

Zentiva_Alvogen
Zentiva CEO Nick Haggar and his Alvogen counterpart Robert Wessman have agreed a deal for Zentiva to buy Alvogen's CEE business • Source: Zentiva

More from Deals

More from Business